65409 Endometriosis Presentation

  • Upload
    bri-ku

  • View
    222

  • Download
    0

Embed Size (px)

Citation preview

  • 7/25/2019 65409 Endometriosis Presentation

    1/58

    Endometriosis

    By

    Lena Gowharji

  • 7/25/2019 65409 Endometriosis Presentation

    2/58

    Ann, is a 35 year old lady,complaining of intermittent

    abdominal pain, bloating and severdysmenorrhoea !he has a previo"shistory of #B!, b"t recently noticedthat her symptoms are all m"ch

    worse in the wee$ before her period %n e&amination she is slim, the

    abdomen was distended, non tender,and no masses were felt 'he "ter"s

    was anteverted, mobile and noabnormalities were fo"nd in theadne&ia

  • 7/25/2019 65409 Endometriosis Presentation

    3/58

    Endometriosis

    Definition( Benign condition in which)hormone dependant* endometrial glandsand stroma are present outside theuterine cavity and wall.

    #ts+ importanceis d"e to its

    - .istressing symptomatology

    /- Association with infertility 3- #nvasive potential )adjacent organs*

    0- .iffic"lty in being diagnosed

  • 7/25/2019 65409 Endometriosis Presentation

    4/58

    Incidence:

    *#ts estimated that 5-51 of women havesome degree of the disease

    23 of women with chronic pelvic pain havevis"ali4ed endometriosis

    2#ts been noted in 5-51 of women"ndergoing gynaecological laparotomies )an"ne&pected finding in 51 of these cases*

  • 7/25/2019 65409 Endometriosis Presentation

    5/58

    Age: #t classically presents in n"lliparo"s

    infertile women in their 30s.

    6owever, it may occ"r at earlier ages)childhood and adolescents* and in s"ch

    cases its associated with obstr"ctive genitalanomalies

    7ollowing menopa"se, it regresses "nless

    estrogen is prescribed 51 of new casesdevelop in that age gro"p

  • 7/25/2019 65409 Endometriosis Presentation

    6/58

    Pathogenesis:is not f"lly "nderstood6owever

    - genetic predisposition

    /- imm"nological changes

    have been reported to clearly play a role

    Several hypotheseshave been "sed toe&plain the vario"s manifestations of thedisease and its vario"s locations

    - 'he 8etrograde menstr"ation theory

    /- 'he 9"llarian metaplasia theory

    3- 'he lymphatic spread theory

    0- 'he hematogeno"s spread theory

  • 7/25/2019 65409 Endometriosis Presentation

    7/58

    ! "he retrograde menstruation

    theory of Sampson: proposes thatendometrial fragments that are shed

    d"ring menstr"ation are transported

    thro"gh the fallopian t"bes, thenbecoming implanted and growing in

    vario"s intra-abdominal sites )'hese

    endometrial fragments are viable and

    capable of growing in vivo and in

    vitro*

  • 7/25/2019 65409 Endometriosis Presentation

    8/58

    #! "he mullarian metaplasia theory of $eyer:proposes that endometriosis res"lts from the

    metaplastic transformation of peritoneal mesotheli"mto endometri"m "nder the infl"ence of certain"nidentified stim"li

    3! "he lymphatic spread theory of %al&an: s"ggests

    that the lymphatics draining the "ter"s transportendometrial tiss"e to vario"s pelvic site where itgrows ectopically

    2:ndometrial tiss"e has been fo"nd in "p to /1 ofpatients with the disease

    '! "he haematogenous spread theory: e&plains thepresence of endometrial tiss"e in distant sites )l"ng,a&illa and forehead*

  • 7/25/2019 65409 Endometriosis Presentation

    9/58

    (hy don)t all menstruating women developendometriosis

    *#t has be fo"nd that the amo"nt of e&pos"re toretrograde menstr"ation and the woman+simm"nological response are most critical

    28esearchers have fo"nd differencesin thechemical composition and biological pathwaysof the endometrial cells in women who haveendometriosis in comparison to those whodon+t

    'hey have also fo"nd a difference in theinflammatory mediators and growth factors inthe peritoneal fl"id of those with endometriosisin comparison to those witho"t

  • 7/25/2019 65409 Endometriosis Presentation

    10/58

    Sites of occurrence:

    2 9ost commonly fo"nd in the dependant portions ofthe pelvis

    - %varies )/ o"t of 3 women with endometriosis*

    /- Broad ligament

    3- ;eritoneal s"rfaces of the c"l-de-sac

    )"terosacral ligaments and post "ently is the recto-sigmoid colon, appendi&,and vesico"terine fold of the peritone"m involved

    2 Laparotomy scars esp after c section ormyomectomy or after the "terine cavity has beenentered

  • 7/25/2019 65409 Endometriosis Presentation

    11/58

  • 7/25/2019 65409 Endometriosis Presentation

    12/58

    Pathology:

    2 'he islands of endometriosis are sensitive toovarian hormones

    2+strogen proliferation

    28egression of corp"s l"te"m and removal ofestrogen and progesteroneca"ses them toslo"gh

    2'hese slo"ghed debris ind"ce a profo"ndinflammatory response that ca"ses significantpain and long term fibrosis

  • 7/25/2019 65409 Endometriosis Presentation

    13/58

    $acroscopical appearance:

    Depends on:site, si4e, time sinceimplantation and day of the menstr"al cycle

  • 7/25/2019 65409 Endometriosis Presentation

    14/58

    $icroscopically:/ o"t of 0 m"st bepresent in the biopsied specimen toconfirm .&

    - endometrial epitheli"m

    /- endometrial glands

    3- endometrial stroma

    0- hemosiderin laden macrophages

  • 7/25/2019 65409 Endometriosis Presentation

    15/58

    +ndometriosis of the ,vary(

    'hese are cysts filled with thic$ chocolatecolo"red fl"id@ which may have a blac$ tarryconsistency sometimes

    2 'his characteristic fl"id represents aged,

    haemolysed blood and des>"amatedepitheli"m

    2 'he glands and stroma lining the cyst+s wallmay be destroyed d"e to an increase in

    press"re 'his leaves behind a fibrotic wallwith infiltrating haemosiderin laydenmacrophages

  • 7/25/2019 65409 Endometriosis Presentation

    16/58

    Risk factors forendometriosis:

    ?"lliparity

    / #nfertility

    3 8eprod"ctive age )"s"ally, late teens

    to 0s*

    0 A first-degree relative with

    endometriosis

    5 8eg"lar menstr"al cycle / daysC ;rolonged menses of D or more days

  • 7/25/2019 65409 Endometriosis Presentation

    17/58

    9any patients are

    asymptomatic

    %thers "s"ally have no positive

    signs at e&amination

  • 7/25/2019 65409 Endometriosis Presentation

    18/58

    The characteristic triadof symptoms:

    - dysmenorrhea

    /- dyspare"nia

    3- dysche4ia

  • 7/25/2019 65409 Endometriosis Presentation

    19/58

  • 7/25/2019 65409 Endometriosis Presentation

    20/58

    Other symptoms:

    7emale reprod"ctive tract(7emale reprod"ctive tract(

    - pre and postmenstr"al spotting

    /- cyclic pelvic pain

    3- low sacral bac$pain )especiallypremenst"ally*

    0- infertility

    5- diminished amo"nt of menstr"al flow

    C- ov"latory pain and mid-cycle vaginal

    bleeding

  • 7/25/2019 65409 Endometriosis Presentation

    21/58

    #f the Bladder is involved(#f the Bladder is involved(

    - cyclic hemat"ria dys"ria

    /- "reteric obstr"ction

    #f the rectosigmoid colon is involved@#f the rectosigmoid colon is involved@

    - premenstr"al tensm"s or diarrhea

    /- obstr"ction

  • 7/25/2019 65409 Endometriosis Presentation

    22/58

    Signs:

    'enderness on biman"al e&amination 'enderness or nod"larity on the posterior

    vaginal forni&

    Eterosacral ligament tenderness or

    nod"larity

  • 7/25/2019 65409 Endometriosis Presentation

    23/58

    Differential diagnosis

  • 7/25/2019 65409 Endometriosis Presentation

    24/58

    Diagnosis

    6istory and e&amination

    ;elvic E!

    .irect vis"ali4ation of endometrioticlesions

    ;athological e&amination of biopsy

    specimen

    :ndometriosis in nota clinical diagnosisF

  • 7/25/2019 65409 Endometriosis Presentation

    25/58

    Diagnosis

    !"spected in afebrile patient with

    the characteristic triad(

    ;elvic pain

    / 7irm, fi&ed tender adne&al

    mass

    3 'ender nod"larity in c"l-de-sacand "terosacral ligament

  • 7/25/2019 65409 Endometriosis Presentation

    26/58

    Diagnosis

    -A #/

    7re>"ently elevated in women

    with endometriosis

    !ensitivity only /1 to 31

    ?ot "sed to diagnose

    endometriosis

  • 7/25/2019 65409 Endometriosis Presentation

    27/58

    Diagnosis

    Definitive diagnosis is generallymade &y:

  • 7/25/2019 65409 Endometriosis Presentation

    28/58

  • 7/25/2019 65409 Endometriosis Presentation

    29/58

  • 7/25/2019 65409 Endometriosis Presentation

    30/58

  • 7/25/2019 65409 Endometriosis Presentation

    31/58

  • 7/25/2019 65409 Endometriosis Presentation

    32/58

    Diagnosis

    (hat do endometriosis lesions loo1 li1e +

  • 7/25/2019 65409 Endometriosis Presentation

    33/58

  • 7/25/2019 65409 Endometriosis Presentation

    34/58

  • 7/25/2019 65409 Endometriosis Presentation

    35/58

  • 7/25/2019 65409 Endometriosis Presentation

    36/58

    Diagnosis

    Enfort"nately, even the most e&perienceds"rgoen may fail to identify endometriosisimplants beca"se(

    'he older implants may have a very s"btleapperance

    'he deeper infiltration lesions may not bevisible at the s"rface

    Biopsy of s"specio"s lesions improvesdiagnosis acc"racy

  • 7/25/2019 65409 Endometriosis Presentation

    37/58

    Staging

    American Society of 2eproductive

    $edicine -AS2$

    :mploys a staging protocol in anattempt to correlate

    7ertility potential with a >"antified stage

    of endometriosis

  • 7/25/2019 65409 Endometriosis Presentation

    38/58

    Staging

    #nitially started to be based on(

    - !ite of involvement

    /- e&tent of vis"ali4ed disease

    And was modified to incl"de(

    .escription of the color of the lesions

    ;ercentage of s"rface involved in eachlesion type

    9ore detailed description of anyendometriosis

  • 7/25/2019 65409 Endometriosis Presentation

    39/58

  • 7/25/2019 65409 Endometriosis Presentation

    40/58

  • 7/25/2019 65409 Endometriosis Presentation

    41/58

  • 7/25/2019 65409 Endometriosis Presentation

    42/58

    #f the fimbriated end of fallopian t"be is completelyenclosed, change the point assignment to C

    .enote appearance of s"perficial implant type as

    8:. I)8*, red, red-pin$, flameli$e, vesic"larblobs, clear vesiclesJ

    H6#': I)H*, opicifications, peritoneal defect,yellow-brownJ

    BLA

  • 7/25/2019 65409 Endometriosis Presentation

    43/58

    Treatment

    ?o treatment

    / ?on-hormonal treatment

    3 6ormonal treatment0 !"rgical treatment

    5 8adiological treatment

  • 7/25/2019 65409 Endometriosis Presentation

    44/58

    I. No treatment

    #f small symptom less lesions

    ;atient observed M e&amined

    every C months

  • 7/25/2019 65409 Endometriosis Presentation

    45/58

    II. Non-hormonaltreatment

    #f small lesions with mild symptoms

    Analgesics are given for pain

    ;rostaglandin inhibitors )napro&en,ib"profen* are given for pain and

    menorrhagia

  • 7/25/2019 65409 Endometriosis Presentation

    46/58

    III. Hormonaltreatment

    Indications:

    !evere symptoms with small pelvis lesions

    / 8ec"rrence of symptoms after conservatives"rgery

    3 9ay be given for a short time )C-/ wee$s*before s"rgery to ma$e dissection easier

    0 After conservative s"rgery to allow anyresid"al lesion to regress

    5 Hhen operation is contraindicated orref"sed by the patient

  • 7/25/2019 65409 Endometriosis Presentation

    47/58

    . !se"do pregnancy

    %v"lation and menstr"ation are inhibitedfor N months )C-D months* "sing acombined %

  • 7/25/2019 65409 Endometriosis Presentation

    48/58

    #. !se"do menopa"se

    Danaol: given orally 0-D mgday for C-N months Hea$ synthetic androgen !ide effects(

    Androgenic effects( acne, male alopecia, hirs"tism, hoarseness ofvoice M hypertrophy of clitoris

    / 6ypo-oestrogenic effects( hot fl"shes, sweating, atrophy of

    breasts, atrophic vaginitis, dry vagina, dyspare"nia M decreasedlibido

    3 Anabolic effects( weight gain M edema

    0 9etabolic effects( impaired gl"cose tolerance, increased ins"linre>"irements in diabetic cases, hepatic dysf"nction Bloodpress"re may be elevated

    5

  • 7/25/2019 65409 Endometriosis Presentation

    49/58

    #. !se"do menopa"se

    4n2% -agonist: ?afarelin )synarel*( intranasally "sing a

    nasal spray, / micrograms twice daily

    Goserelin )4olade&*( 3C mg injected !